DUBLIN--(BUSINESS WIRE)--The "Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026" report has been added to ResearchAndMarkets.com's offering.
Global Meningococcal Vaccines Market: Overview
This report analyzes the current and future scenario of the global meningococcal vaccines market. Advancements in healthcare, increase in awareness and education through various non-profit organizations, and a rise in patient awareness and health care expenditure are key factors that are projected to drive the global market during the forecast period.
The global meningococcal vaccines market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on type, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global meningococcal vaccines market.
Key Topics Covered:
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Meningococcal Vaccines Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Market Trends
4.4. Global Meningococcal Vaccines Market Analysis and Forecast, 2016-2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter's Five Force Analysis
5. Market Outlook
5.1.Pipeline Analysis
5.2. Epidemiology Of Meningococcal Disease
5.3. Regulatory Scenario.
6. Global Meningococcal Vaccines Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Meningococcal Vaccines Market Value Forecast, by Type, 2016-2026
6.3.1. Polysaccharide
6.3.1.1. Menomune
6.3.1.2. Mencevax
6.3.1.3. NmVac4
6.3.1.4. Others
6.3.2. Conjugate Vaccines
6.3.2.1. Menactra
6.3.2.2. Menveo
6.3.2.3. NeisVac-C
6.3.2.4. Nimenrix
6.3.2.5. Meningitec
6.3.2.6. Menjugate
6.3.2.7. MenAfriVac
6.3.2.8. NmVac4-DT
6.3.3. Combination Vaccines
6.3.3.1. MenHibrix
6.3.3.2. Menitorix
6.3.4. Men B Vaccines
6.3.4.1. Bexsero
6.3.4.2. Trumenba
6.3.5. Others
7. Global Meningococcal Vaccines Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Meningococcal Vaccines Market Value Forecast, by End-user, 2016-2026
7.3.1. Retail Pharmacies
7.3.2. Hospital Pharmacies
7.3.3. Others
7.4. Global Meningococcal Vaccines Market Attractiveness, by End-user
8. Global Meningococcal Vaccines Market Analysis and Forecast, by Region/Sub-Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia-Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Meningococcal Vaccines Market Attractiveness, by Region/Sub-Region
9. North America Meningococcal Vaccines Market Analysis and Forecast
9.1. Introduction
9.2. North America Meningococcal Vaccines Market Value Forecast, by Type, 2016-2026
9.3. North America Meningococcal Vaccines Market Value Forecast, by End-user, 2016-2026
9.4. North America Meningococcal Vaccines Market Value Forecast, by Country, 2016-2026
9.5. North America Meningococcal Vaccines Market Attractiveness Analysis
10. Europe Meningococcal Vaccines Market Analysis and Forecast
11. Asia-Pacific Meningococcal Vaccines Market Analysis and Forecast
12. Latin America Meningococcal Vaccines Market Analysis and Forecast
13. Middle East & Africa Meningococcal Vaccines Market Analysis and Forecast
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Competitive Business Strategies
14.3. Company Profiles
14.3.1. Neuron Biotech
14.3.2. Baxter international
14.3.3. Pfizer Inc.
14.3.4. Novartis International
14.3.5. Sanofi S.A
14.3.6. JN-International Medical Corporation
14.3.7. Biomed Pvt. Ltd.
14.3.8. Serum Institute of India Ltd
14.3.9. GlaxoSmithKline plc
For more information about this report visit https://www.researchandmarkets.com/r/vi01sy
